• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Alembic Pharmaceuticals Limited — Updates, 11-12-2025: Press Release

    11-12-2025 | 11:54 am

    Alembic Pharma secured USFDA final approval for Loteprednol Etabonate and Tobramycin Ophthalmic Suspension, targeting ocular infections. This approval grants 180 days of market advantage post-launch. A key business win.

    No comments yet. Be the first to comment!

    All announcements from Alembic Pharmaceuticals Limited